Revenue by Business Segment

2024-10-01 to 2024-12-31

Swipe to see the full flow
CENCORA, INC. (COR) FY2025 Q1 P&L / Income StatementIncome statement for 2024-10-01 through 2024-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETU.S. Healthcare SolutionsInternational Healthcare SolutionsRevenueRevenue before reconciliation (calculated)Intersegment eliminationsGross profitCost of goods soldOperating incomeOperating expenses (calculated)Distribution, selling, and administrativeAmortizationDepreciationAcquisition-related deal and integration expensesLitigation and opioid-related expenses (credit), netRestructuring and other expensesIncome before income taxesOther income (expense), net (calculated)Net incomeIncome tax expenseRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$81.49 BRevenueRevenue$81.49 BGross profitGross profit$2.56 BOperating incomeOperating income$706.25 MIncome before income taxesPretax income$620.45 MNet incomeNet income$493.72 MOperating expenses (calculated)Operating expenses(calculated)$1.85 BCost of goods soldCost of goods sold$78.93 BIncome tax expenseIncome tax expense$126.73 MDistribution, selling, and administrativeDistribution, selling,and administrative$1.47 BOther income (expense), net (calculated)Other income,net (calculated)−$85.81 MU.S. Healthcare SolutionsU.S. HealthcareSolutions$74.03 BAmortizationAmortization$165.78 MDepreciationDepreciation$112.71 MAcquisition-related deal and integration expensesAcquisition-related dealand integration expenses$38.71 MInternational Healthcare SolutionsInternationalHealthcare Solutions$7.46 BLitigation and opioid-related expenses (credit), netLitigation and opioid-relatedexpenses (credit), net$16.77 MIntersegment eliminationsIntersegmenteliminations−$3.41 MRestructuring and other expensesRestructuring and other expenses$45.76 M
Chart details

CENCORA, INC. (COR) FY2025 Q1 P&L / Income Statement

Income statement for 2024-10-01 through 2024-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue
81,487,060,000 US dollars
Cost of goods sold
78,929,022,000 US dollars
Gross profit
2,558,038,000 US dollars
Operating expenses (calculated)
1,851,784,000 US dollars
Operating income
706,254,000 US dollars
Other income (expense), net (calculated)
negative 85,807,000 US dollars
Income before income taxes
620,447,000 US dollars
Income tax expense
126,728,000 US dollars
Net income
493,719,000 US dollars
U.S. Healthcare Solutions
74,033,128,000 US dollars
International Healthcare Solutions
7,457,341,000 US dollars
Amortization
165,780,000 US dollars
Litigation and opioid-related expenses (credit), net
16,765,000 US dollars
Acquisition-related deal and integration expenses
38,712,000 US dollars
Restructuring and other expenses
45,760,000 US dollars
Depreciation
112,712,000 US dollars
Distribution, selling, and administrative
1,472,055,000 US dollars
Revenue before reconciliation (calculated)
81,490,469,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Intersegment eliminations
negative 3,409,000 US dollars. Reported reconciliation to consolidated revenue.
U.S. Healthcare Solutions costs (calculated)
73,265,784,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
International Healthcare Solutions costs (calculated)
7,275,248,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
239,774,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to CENCORA, INC.: $488.60 M; to noncontrolling interests: $5.12 M.
CENCORA, INC. (COR) FY2025 Q1 P&L / Income Statement Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

3.1%

Gross profit / revenue

Operating margin

0.9%

Operating profit / revenue

Cash conversion

−550.7%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!